
Novo Nordisk (NVO) stock extended gains on Friday after the pharmaceutical giant announced a partnership with Amazon Pharmacy for its FDA-approved oral weight-loss pill.
According to its press release, Amazon Pharmacy will offer access to oral Wegovy at competitive price points starting at $25 for insured patients and $149 for uninsured customers.